Analysts Set Varex Imaging (NASDAQ:VREX) PT at $16.17

Shares of Varex Imaging (NASDAQ:VREX) have been given an average recommendation of “Moderate Buy” by the five ratings firms that are currently covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation, two have issued a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month price objective among brokerages that have issued a report on the stock in the last year is $16.1667.

Several equities research analysts recently issued reports on VREX shares. Zacks Research raised shares of Varex Imaging from a “hold” rating to a “strong-buy” rating in a research note on Monday, April 13th. B. Riley Financial reissued a “buy” rating on shares of Varex Imaging in a research report on Thursday, February 12th. Wall Street Zen upgraded Varex Imaging from a “buy” rating to a “strong-buy” rating in a research note on Saturday, February 28th. Jefferies Financial Group reaffirmed a “hold” rating and set a $14.50 target price on shares of Varex Imaging in a research report on Monday, February 2nd. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of Varex Imaging in a research note on Friday, March 27th.

Insider Transactions at Varex Imaging

In other news, Director Jay K. Kunkel sold 4,510 shares of the stock in a transaction that occurred on Friday, March 20th. The stock was sold at an average price of $11.14, for a total transaction of $50,241.40. Following the completion of the transaction, the director directly owned 23,450 shares in the company, valued at approximately $261,233. This represents a 16.13% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 4.60% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Varex Imaging

Several large investors have recently added to or reduced their stakes in the company. Vanguard Group Inc. grew its position in shares of Varex Imaging by 4.4% during the third quarter. Vanguard Group Inc. now owns 2,989,847 shares of the company’s stock worth $37,074,000 after acquiring an additional 126,396 shares during the last quarter. Cooke & Bieler LP boosted its stake in Varex Imaging by 2.2% during the 4th quarter. Cooke & Bieler LP now owns 1,632,525 shares of the company’s stock valued at $19,019,000 after purchasing an additional 35,042 shares during the period. Neuberger Berman Group LLC boosted its stake in Varex Imaging by 1.4% during the 3rd quarter. Neuberger Berman Group LLC now owns 1,518,674 shares of the company’s stock valued at $18,810,000 after purchasing an additional 21,499 shares during the period. LSV Asset Management grew its position in Varex Imaging by 210.7% in the 4th quarter. LSV Asset Management now owns 1,244,329 shares of the company’s stock worth $14,496,000 after purchasing an additional 843,805 shares during the last quarter. Finally, Rice Hall James & Associates LLC grew its position in Varex Imaging by 19.1% in the 4th quarter. Rice Hall James & Associates LLC now owns 1,082,964 shares of the company’s stock worth $12,617,000 after purchasing an additional 173,703 shares during the last quarter.

Varex Imaging Stock Performance

Varex Imaging stock opened at $12.01 on Wednesday. The firm has a market capitalization of $503.22 million, a PE ratio of -7.32 and a beta of 0.99. Varex Imaging has a one year low of $6.76 and a one year high of $14.56. The stock’s 50 day moving average price is $11.94 and its 200 day moving average price is $12.14. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.87 and a current ratio of 3.89.

Varex Imaging (NASDAQ:VREX) last issued its quarterly earnings data on Tuesday, February 10th. The company reported $0.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.14 by $0.05. The company had revenue of $209.60 million during the quarter, compared to the consensus estimate of $207.83 million. Varex Imaging had a negative net margin of 7.92% and a positive return on equity of 8.43%. Varex Imaging has set its Q2 2026 guidance at 0.150-0.250 EPS. As a group, sell-side analysts expect that Varex Imaging will post 0.53 EPS for the current fiscal year.

Varex Imaging Company Profile

Varex Imaging Corporation is a global provider of X-ray imaging components and solutions for the medical, security and industrial markets. The company designs, develops and manufactures a broad range of products that convert X-ray energy into high-resolution digital images. Its portfolio includes X-ray tubes, flat panel detectors, digital sensors, specialty radiographic tubes and related software, all engineered to meet the demanding requirements of original equipment manufacturers (OEMs) in diagnostic imaging, computed tomography (CT), fluoroscopy, mammography, dental radiography and non-destructive testing applications.

The company’s medical imaging offerings support a wide spectrum of clinical modalities, from portable radiography systems to advanced CT scanners, enhancing image quality and dose efficiency for healthcare providers.